Is it time to switch to doxycycline from azithromycin for treating genital chlamydial infections in women? Modelling the impact of autoinoculation from the gastrointestinal tract to the genital tract
暂无分享,去创建一个
Andrew P. Craig | J. Hocking | R. Rank | B. Donovan | Laxmi Yeruva | F. Kong | D. Wilson
[1] J. Hocking,et al. The efficacy of azithromycin and doxycycline for the treatment of rectal chlamydia infection: a systematic review and meta-analysis. , 2015, The Journal of antimicrobial chemotherapy.
[2] S. Plitt,et al. Evidence for increased Chlamydia case finding after the introduction of rectal screening among women attending 2 Canadian sexually transmitted infection clinics. , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[3] J. Hocking,et al. Treatment of rectal chlamydia infection may be more complicated than we originally thought. , 2014, The Journal of antimicrobial chemotherapy.
[4] C. Hoebe,et al. Antibiotic Use before Chlamydia and Gonorrhea Genital and Extragenital Screening in the Sexually Transmitted Infection Clinical Setting , 2014, Antimicrobial Agents and Chemotherapy.
[5] R. Guy,et al. Azithromycin versus doxycycline for the treatment of genital chlamydia infection: a meta-analysis of randomized controlled trials. , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[6] R. Challenor,et al. Rectal Chlamydia in heterosexual women: more questions than answers , 2014, International journal of STD & AIDS.
[7] C. Hoebe,et al. High co-occurrence of anorectal chlamydia with urogenital chlamydia in women visiting an STI clinic revealed by routine universal testing in an observational study; a recommendation towards a better anorectal chlamydia control in women , 2014, BMC Infectious Diseases.
[8] R. Rank,et al. Hidden in Plain Sight: Chlamydial Gastrointestinal Infection and Its Relevance to Persistence in Human Genital Infection , 2014, Infection and Immunity.
[9] R. Rank,et al. Differential Susceptibilities to Azithromycin Treatment of Chlamydial Infection in the Gastrointestinal Tract and Cervix , 2013, Antimicrobial Agents and Chemotherapy.
[10] R. Rank,et al. Chlamydial infection of the gastrointestinal tract: a reservoir for persistent infection. , 2013, Pathogens and disease.
[11] H. Handsfield. Questioning azithromycin for chlamydial infection. , 2011, Sexually transmitted diseases.
[12] J. Greene,et al. Hidden in plain sight marketing prescription drugs to consumers in the twentieth century. , 2010, American journal of public health.
[13] A. Davies,et al. Incidence and reinfection rates of genital chlamydial infection among women aged 16–24 years attending general practice, family planning and genitourinary medicine clinics in England: a prospective cohort study by the Chlamydia Recall Study Advisory Group , 2006, Sexually Transmitted Infections.
[14] C. Lau,et al. Azithromycin Versus Doxycycline for Genital Chlamydial Infections: A Meta-Analysis of Randomized Clinical Trials , 2002, Sexually transmitted diseases.
[15] L. Perry,et al. Chlamydial Colonization of Multiple Mucosae following Infection by Any Mucosal Route , 1999, Infection and Immunity.
[16] E. Hook,et al. Measured versus self-reported compliance with doxycycline therapy for chlamydia-associated syndromes: high therapeutic success rates despite poor compliance. , 1999, Sexually transmitted diseases.
[17] K. Workowski,et al. Long-term eradication of Chlamydia trachomatis genital infection after antimicrobial therapy. Evidence against persistent infection. , 1993, JAMA.
[18] R. Sweet,et al. Prospective study of perinatal transmission of Chlamydia trachomatis. , 1986, JAMA.